Development of a lung-liver in vitro coculture model for inhalation-like toxicity assessment

Toxicol In Vitro. 2023 Oct:92:105641. doi: 10.1016/j.tiv.2023.105641. Epub 2023 Jul 10.

Abstract

Animal models are considered prime study models for inhalation-like toxicity assessment. However, in light of animal experimentation reduction (3Rs), we developed and investigated an alternative in vitro method to study systemic-like responses to inhalation-like exposures. A coculture platform was established to emulate inter-organ crosstalks between a pulmonary barrier, which constitutes the route of entry of inhaled compounds, and the liver, which plays a major role in xenobiotic metabolism. Both compartments (Calu-3 insert and HepG2/C3A biochip) were jointly cultured in a dynamically-stimulated environment for 72 h. The present model was characterized using acetaminophen (APAP), a well-documented hepatotoxicant, to visibly assess the passage and circulation of a xenobiotic through the device. Based on viability and functionality parameters the coculture model showed that the bronchial barrier and the liver biochip can successfully be maintained viable and function in a dynamic coculture setting for 3 days. In a stress-induced environment, present results reported that the coculture model emulated active and functional in vitro crosstalk that seemingly was responsive to xenobiotic exposure doses. The hepatic and bronchial cellular responses to xenobiotic exposure were modified in the coculture setting as they displayed earlier and stronger detoxification processes, highlighting active and functional organ crosstalk between both compartments.

Keywords: Bioengineering; Coculture; Lung-liver crosstalk; Multiorgan-on-a-chip; Toxicology.

MeSH terms

  • Acetaminophen / toxicity
  • Animals
  • Coculture Techniques
  • Liver* / metabolism
  • Lung
  • Xenobiotics* / metabolism
  • Xenobiotics* / toxicity

Substances

  • Xenobiotics
  • Acetaminophen